Another chink and the amyloid hypothesis of Alzheimer’s that has soaked up massive amounts of drug development money with little clinical impact.

https://www.science.org/content/article/resea...red-images

It will be amazing if the Leronlimab Alzheimer’s investigator initiated trial in mild to moderate patients is able to shine a spotlight on inflammation and immune dysregulation, perhaps related to amyloid deposition, as the real trigger for cognitive decline.